Provided is a compound represented by the formula (I):
wherein each symbol is as defined in the specification, or a salt thereof, which has an AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor potentiating action. The compound of the present invention is useful as a prophylactic or therapeutic drug for depression, schizophrenia, Alzheimer's disease or attention deficit hyperactivity disorder (ADHD) and the like.
提供的化合物由公式(I)表示,其中每个符号如规范中所定义,或其盐,具有
AMPA(α-
氨基-3-羟基-5-
甲基-4-异唑烷
丙酸)受体增强作用。本发明的化合物可用作预防或治疗抑郁症、精神分裂症、阿尔茨海默病或注意力缺陷多动障碍(AD
HD)等疾病的药物。